No abstract available
Keywords:
Rheumatic diseases; anti-TNF agents; immunogenicity; safety.
MeSH terms
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / pharmacology
-
Antirheumatic Agents / therapeutic use
-
Drug Design
-
Humans
-
Rheumatic Diseases / drug therapy*
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha